Close Menu

NEW YORK – Bio-Techne said today that its fiscal 2019 fourth quarter revenues rose 6 percent over fiscal Q4 2018.

For the three months ended June 30, the firm reported revenues of $191.7 million compared to $180.3 million in Q4 2018, missing analysts' average estimate of $197.8 million. On an organic basis, fiscal Q4 revenues rose 7 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.